Cargando…
新型Ⅰ类和Ⅱb类选择性HDAC抑制剂甲磺酸普依司他治疗弥漫大B细胞淋巴瘤的体外药效学和作用机制研究
OBJECTIVE: To investigate the in vitro inhibitory activity of a novel class Ⅰ and Ⅱb selective histone deacetylase（HDAC）inhibitor, purinostat mesylate（PM）, in diffuse large B-cell lymphoma and its mechanism. METHODS: The 3-（4,5-dimethylthiazol-2-yl）-2,5-diphenyl tetrazolium bromide method was used t...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613491/ https://www.ncbi.nlm.nih.gov/pubmed/36709169 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.09.007 |